Hypertrophic cardiomyopathy

@article{Maron2013HypertrophicC,
  title={Hypertrophic cardiomyopathy},
  author={B. Maron and M. Maron},
  journal={The Lancet},
  year={2013},
  volume={381},
  pages={242-255}
}
  • B. Maron, M. Maron
  • Published 2013
  • Medicine
  • The Lancet
    • Hypertrophic cardiomyopathy is a common inherited cardiovascular disease present in one in 500 of the general population. It is caused by more than 1400 mutations in 11 or more genes encoding proteins of the cardiac sarcomere. Although hypertrophic cardiomyopathy is the most frequent cause of sudden death in young people (including trained athletes), and can lead to functional disability from heart failure and stroke, the majority of affected individuals probably remain undiagnosed and many do… CONTINUE READING
    View on Elsevier
    doi.org
    172 Citations
    Highly Influencial Citations
    17
    Background Citations
    107
    Methods Citations
    12
    Results Citations
    3

    Paper Mentions

    Interventional Clinical Trial
    Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy
    Hypertrophic Cardiomyopathy (HCM) is the most common hereditary heart disease with high mortality. Heart failure is the most common complication (about 50% incidence) in these… Expand
    ConditionsFibrosis, Hypertrophic Cardiomyopathy
    InterventionDrug
    Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
    May 2018 - July 2020
    Blog Post
    Hipertrofik Kardiyomiyopati (HKMP)
    FOAM EM RSSFOAM EM RSS
    29 December 2013
    Blog Post
    Richard Lehman’s journal review—21 January 2013
    Latest BMJ blogs
    21 January 2013
    172 Citations
    Citation Type

    Citation Type

    Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
    • 395
    • PDF
    Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management
    • 6
    Hypertrophic cardiomyopathy in the developing world: focus on India.
    • 10
    • Highly Influenced
    • PDF
    Clinical and Pathological Impact of Tissue Fibrosis on Lethal Arrhythmic Events in Hypertrophic Cardiomyopathy Patients With Impaired Systolic Function.
    • Y. Wada, T. Aiba, +17 authors H. Ogawa
    • Medicine
    • Circulation journal : official journal of the Japanese Circulation Society
    • 2015
    • 18
    • PDF
    Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.
    • 8
    • PDF
    Sudden cardiac death.
    • 23
    • Highly Influenced
    • PDF
    Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    • 157
    Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    • 17
    Role of cardiac MRI in detecting familial hypertrophic cardiomyopathy : Review / Marymol Koshy … [et al.]
    • PDF
    The Genetic and Molecular Bases for Hypertrophic Cardiomyopathy: The Role for Calcium Sensitization.
    • 13

    References

    SHOWING 1-10 OF 142 REFERENCES
    Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
    • 78
    Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.
    • 464
    • PDF
    Genetics and Clinical Destiny: Improving Care in Hypertrophic Cardiomyopathy
    • C. Ho
    • Medicine
    • Circulation
    • 2010
    • 118
    Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy
    • 428
    Genetic Basis of Hypertrophic Cardiomyopathy: From Bench to the Clinics
    • 351
    Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.
    • 338
    Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.
    • 922
    Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy.
    • 81
    Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    • 481
    Determinants for clinical diagnosis of hypertrophic cardiomyopathy.
    • 51